BI Logo 288 12mm tall (1)

Boehringer-Ingelheim- Lunch Session

Dabigatran 2016: Innovation in Anticoagulation Care

12:30 – 12:45 Gathering
12:45 – 13:00 Opening: Anticoagulation Care 3.0 – NOACs in 2016 and Beyond
Professor Dan Atar, MD, FESC
Dept. of Cardiology B,
Oslo University Hospital,
Vice-President of the ESC,
Norway
 13:00 – 13:20 Real-world Experience with Dabigatran – Reassurance for Daily Practice
Professor Yoseph Rozenman, 
MSc, MD, FESC, FACC
Head, Cardiovascular Institute
The Edith Wolfson Medical Center
Immediate Past President, Israel Heart Society
13:20 – 13:40 Innovation in Anticoagulation Care: Availability of the Antidote –Closing the Circle
Professor Chaim Lotan MD, FACC, FESC,
Chairman of the Cardiovascular Division,
Hadassah Medical Center,
Immediate Past President – Israel Heart Society,
Co-Course Director ICI meeting ,
Jerusalem, Israel
13:40 – 14:00 Panel Discussion - Clinical Cases In Which The Antidote “Made The Difference”
Professor Michael Glikson
, MD, FACC, FESC
Director of Davidai Arrhythmia Center
President of Israel Heart Society
Leviev Heart Center, Sheba Medical Center
14:00 – 14:10  Q & A